Water-solubility of drugs is one of the most important properties that determine whether the drugs are clinically useful or not. Thus, a new approach that can increase the water- solubility of poorly soluble drugs by orders of magnitude would help more effective use of existing drugs and new drugs in the development stage. The objective of this project is to develop oral paclitaxel formulations using hydrotropic polymers that can increase the paclitaxel solubility by 2 approximately 4 orders of magnitude in aqueous solution. The central hypothesis of this project is that the increase in paclitaxel solubility results in improved bioavailability after oral administration.
The specific aims of this project are: (1) to identify the structural requirements necessary for increasing water solubilities of paclitaxel using various low molecular weight hydrotropic agents; (2) to synthesize hydrotropic polymers based on the structures of the low molecular weight hydrotropic agents identified in Specific Aim 1; (3) to prepare paclitaxel formulations using hydrotropic polymers for oral administration; (4) to test increased cytotoxicity of paclitaxel in hydrotropic polymer formulations using human tumor cell lines; and (5) to define the bioavailability of paclitaxel in hydrotropic polymer formulations using an in vivo chronically catheterized rat model. The significance of this project is that, upon successful completion, we will be able to dissolve paclitaxel in water as if it is a freely soluble drug with aqueous solubility of 1 approximately 10 mg/ml. The high water solubility of paclitaxel will make it possible to develop more patient-friendly formulations with reduced or no undesirable side effects. In addition, the approach used for paclitaxel can be used for other poorly soluble drugs. This will allow more effective use of existing drugs and development of various new drug candidates that are otherwise eliminated from further consideration due to their poor water-solubilities.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
1R01GM065284-01
Application #
6463340
Study Section
Surgery and Bioengineering Study Section (SB)
Program Officer
Okita, Richard T
Project Start
2002-04-01
Project End
2005-03-31
Budget Start
2002-04-01
Budget End
2003-03-31
Support Year
1
Fiscal Year
2002
Total Cost
$258,611
Indirect Cost
Name
Purdue University
Department
Type
Schools of Pharmacy
DUNS #
072051394
City
West Lafayette
State
IN
Country
United States
Zip Code
47907
Lu, Ying; Park, Kinam (2013) Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs. Int J Pharm 453:198-214
Lee, Seung-Young; Kim, Sungwon; Tyler, Jacqueline Y et al. (2013) Blood-stable, tumor-adaptable disulfide bonded mPEG-(Cys)4-PDLLA micelles for chemotherapy. Biomaterials 34:552-61
Park, Kinam (2013) Facing the truth about nanotechnology in drug delivery. ACS Nano 7:7442-7
Kim, Ji Young; Kim, Sungwon; Pinal, Rodolfo et al. (2011) Hydrotropic polymer micelles as versatile vehicles for delivery of poorly water-soluble drugs. J Control Release 152:13-20
Lu, Ying; Kim, Sungwon; Park, Kinam (2011) In vitro-in vivo correlation: perspectives on model development. Int J Pharm 418:142-8
Kim, Ji Young; Kim, Sungwon; Papp, Michelle et al. (2010) Hydrotropic solubilization of poorly water-soluble drugs. J Pharm Sci 99:3953-65
Kim, Sungwon; Kim, Jong-Ho; Jeon, Oju et al. (2009) Engineered polymers for advanced drug delivery. Eur J Pharm Biopharm 71:420-30
Kim, Sungwon; Kim, Ji Young; Huh, Kang Moo et al. (2008) Hydrotropic polymer micelles containing acrylic acid moieties for oral delivery of paclitaxel. J Control Release 132:222-9
Chen, Hongtao; Kim, Sungwon; He, Wei et al. (2008) Fast release of lipophilic agents from circulating PEG-PDLLA micelles revealed by in vivo forster resonance energy transfer imaging. Langmuir 24:5213-7
Huh, Kang Moo; Min, Hyun Su; Lee, Sang Cheon et al. (2008) A new hydrotropic block copolymer micelle system for aqueous solubilization of paclitaxel. J Control Release 126:122-9

Showing the most recent 10 out of 21 publications